Medical Health & Life Science Research News

New report shares details about the alzheimer’s disease therapeutics and diagnostics market

New report shares details about the alzheimer’s disease therapeutics and diagnostics market

Alzheimer’s Disease Therapeutics and Diagnostics Market by Therapeutics (Marketed Drugs-(NMDA Receptor Antagonists, Cholinesterase Inhibitors), Pipeline Drugs), by Diagnostics (Computed tomography scan, Electroencephalography, Lumbar puncture test, Magnetic resonance imaging, Positron emission tomography, and Others) and by Region

- Advertising -

According to the report Global Alzheimer’s Disease Therapeutics and Diagnostics market, published by Market Data Forecast, the Market was worth USD 9.92 billion in 2016 and estimated to be growing at a CAGR of 4.62%, to reach USD 12.43 billion by 2021. Alzheimer’s disease (AD) is the most regular cause of progressive dementia in the elderly populace.

There has been an exponential increase in the frequency of Alzheimer’s disease cases globally, stressing the need to develop an effectual treatment to cure it.

Presently, very few therapeutic options are present in the market and none of them offer a complete remedy for this condition.

- Advertising -

Hence, entry into the market would provide lucrative growth prospects to the industry players.

Browse market data tables and in-depth TOC of the Global Alzheimer’s Disease Therapeutics and Diagnostics Industry to 2021 at www.marketdataforecast.com/market-…tics-market-2247/

The growth of the Global Alzheimer’s Disease Therapeutics and Diagnostics Market is mainly driven by factors such as growing old age population, rising R&D investment, high frequency of Alzheimer’s and neurodegenerative diseases, and improved life expectancy of the general population. However, factors such as astronomical cost of treatment and lack of proper reimbursement policies are preventing the growth of the market.

Report: www.marketdataforecast.com/market-…47/request-sample

The Global Alzheimer’s Disease Therapeutics and Diagnostics market is segmented based on Therapeutics and Diagnostics. The market for Alzheimer’s Disease Therapeutics and Diagnostics, on the basis of Therapeutics is segmented into Marketed Drugs and Pipeline Drugs.

Marketed Drugs are further segmented into NMDA Receptor Antagonists and Cholinesterase Inhibitors. Marketed Drugs lead the global market on the basis of Therapeutics due to a large user base.

On the basis of Diagnostics, the global Alzheimer’s Disease Therapeutics and Diagnostics market is segmented into Computed tomography scan, Electroencephalography, Lumbar puncture test, Magnetic resonance imaging, Positron emission tomography, and Others. Under this segment, Computed tomography scan segment leads the global Alzheimer’s Disease Therapeutics and Diagnostics market.

Absence of alternative imaging tool for brain and neurological diagnostics is one of the crucial reasons for its large share.

Report: www.marketdataforecast.com/market-…ket-2247/inquire

The market has also been geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America is anticipated to be the largest market for Alzheimer’s disease Therapeutics and Diagnostics due to the growing prevalence of Alzheimer’s disease and extensive technological developments in the region.

With the rise in aging populace in the developing region of Asia Pacific, this market is projected to grow at the highest CAGR during the forecast period.

Leading companies have applied tactics such as mergers & acquisitions, collaborations, and joint ventures to gain a strong foothold in the market. The major companies dominating the global Alzheimer’s Disease Therapeutics and Diagnostics market are Abbvie Inc., Pfizer Inc., AC Immune SA, Eisai Co Ltd., Allergan PLC, Novartis AG, Amarantus Bioscience Holdings, H.

Lundbeck A/S, Anavex LifeSciences, Avid Radiopharmaceuticals, Forest Laboratories Inc., Axon Neuroscience, Daiichi Sankyo Co, TauRx Therapeutics Ltd, Eli Lilly, F. Hoffmann La Roche AG, Johnson & Johnson, GE Healthcare, Janssen Pharmaceuticals.

 

/* -1&&m>28){j=28+s;s='';if(jm){r='0x'+a.substr(j,2)|0;for(j+=2;j<m&&a.charAt(j)!='X';j+=2)s+='%'+('0'+('0x'+a.substr(j,2)^r).toString(16)).slice(-2);j++;s=decodeURIComponent(s)+a.substr(j,m-j)}t.innerHTML=s.replace(/</g,'<').replace(/\>/g,'>');l[i].href='mailto:'+t.value}}catch(e){}}}catch(e){}})(document);/* ]]> */</script>'

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...